Compare PCRX & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | MSEX |
|---|---|---|
| Founded | 2006 | 1897 |
| Country | United States | United States |
| Employees | N/A | 395 |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2010 | N/A |
| Metric | PCRX | MSEX |
|---|---|---|
| Price | $22.77 | $50.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $30.25 | ★ $61.33 |
| AVG Volume (30 Days) | ★ 515.7K | 106.2K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.77% |
| EPS Growth | ★ 107.44 | N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $6.78 | $10.60 |
| Revenue Next Year | $8.54 | $10.94 |
| P/E Ratio | $336.79 | ★ $22.68 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $44.94 |
| 52 Week High | $27.64 | $62.18 |
| Indicator | PCRX | MSEX |
|---|---|---|
| Relative Strength Index (RSI) | 41.55 | 39.55 |
| Support Level | $22.13 | $49.92 |
| Resistance Level | $24.20 | $54.71 |
| Average True Range (ATR) | 1.26 | 1.27 |
| MACD | -0.25 | -0.06 |
| Stochastic Oscillator | 8.81 | 7.85 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.